Acute focal dystonia induced by a tricyclic antidepressant in a patient with Wilson disease: a case report

Pfeiffer, 2007, Wilson's disease, Semin Neurol, 27, 123, 10.1055/s-2007-971173

Roberts, 2008, Diagnosis and treatment of Wilson's disease: an update, Hepatology, 47, 2089, 10.1002/hep.22261

Wilson, 1912, Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver, Brain, 34, 20, 10.1093/brain/34.4.295

Brewer, 2005, Wilson's disease: clinical management and therapy, J Hepatol, 42, 13, 10.1016/j.jhep.2004.11.013

Brewer, 2005, Neurologically presenting Wilson's disease, CNS Drugs, 19, 185, 10.2165/00023210-200519030-00001

Czlonkowska, 2005, Wilson's disease – cause of mortality in 164 patients during 1992-2003 observation period, J Neurol, 252, 698, 10.1007/s00415-005-0720-4

Domínguez-Morán, 2001, Acute paroxysmal dystonia induced by fluoxetine, Mov Disord, 16, 767, 10.1002/mds.1154

Gill, 1997, Extrapyramidal symptoms associated with cyclic antidepressant treatment: a review of the literature and consolidating hypotheses, J Clin Psychopharmacol, 17, 377, 10.1097/00004714-199710000-00007

López-Alemany, 1997, Akathisia and acute dystonia induced by sumatriptan, J Neurol, 244, 131, 10.1007/s004150050062

Van Harten, 1999, Acute dystonia induced by drug treatment, Br Med J, 319, 623, 10.1136/bmj.319.7210.623

Madhusoodanan, 2010, Extrapyramidal symptoms associated with antidepressants – a review of the literature and a analysis of spontaneous reports, Ann Clin Psychiatry, 22, 148

Foster, 1959, Disturbances of motor function during treatment with imipramine, Br Med J, 2, 1452, 10.1136/bmj.2.5164.1452

Schillevoort, 2002, Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors: a case control study using spontaneous reports, Int Clin Psychopharmacol, 17, 75, 10.1097/00004850-200203000-00006

Deuschle, 2006, Dyskinesia during treatment with duloxetine, Pharmacopsychiatry, 39, 237, 10.1055/s-2006-951608

Patel, 2006, Oculogyric dystonic reaction to escitalopram with features of anaphylaxis including response to epinephrine, Int Arch Allergy Immunol, 140, 27, 10.1159/000091840

Najjar, 2004, Citalopram and dystonia, J Am Acad Child Adolesc Psychiatry, 43, 8, 10.1097/00004583-200401000-00008

Hendenmalm, 2006, Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphisms, J Clin Psychopharmacol, 26, 192, 10.1097/01.jcp.0000203200.96205.34

Shin, 2012, Drug induced parkinsonism, J Clin Neurol, 8, 15, 10.3988/jcn.2012.8.1.15

Robottom, 2012, Drug-induced movement disorders: emergencies and management, Neurol Clin, 30, 309, 10.1016/j.ncl.2011.09.007

Bondon-Guitton, 2011, Drug-induced parkinsonism: a review of 17 years experience in a regional pharmacovigilance center in France, Mov Disord, 26, 2226, 10.1002/mds.23828

Litwin, 2012, Gender differences in Wilson's disease, J Neurol Sci, 312, 31, 10.1016/j.jns.2011.08.028